Table 4
Mean (SD) QOL scores over time: baseline and final assessment (month 3)
| Placebo | Azithromycin | |||||
|---|---|---|---|---|---|---|
| n | QOL score | n | QOL score | p value* | ||
| *Interaction of treatment effect and time. **Minimum and maximum score possible for each domain. | ||||||
| Dyspnoea | Baseline | 28 | 22.75 (4.86) | 28 | 21.96 (4.68) | 0.042 |
| (range 5–35)** | Final | 19 | 25.82 (5.27) | 22 | 28.16 (4.76) | |
| Fatigue | Baseline | 30 | 18.87 (5.37) | 30 | 17.17 (5.50) | 0.003 |
| (range 4–28) | Final | 20 | 18.85 (4.70) | 24 | 21.04 (4.12) | |
| Emotion | Baseline | 30 | 37.97 (6.84) | 30 | 34.87 (7.63) | 0.012 |
| (range 7–49) | Final | 20 | 39.70 (5.66) | 24 | 41.33 (7.13) | |
| Master | Baseline | 30 | 24.37 (3.69) | 30 | 22.70 (5.47) | 0.035 |
| (range 4–28) | Final | 20 | 25.25 (3.64) | 24 | 25.54 (3.45) | |
| Total | Baseline | 28 | 103.14 (14.00) | 29 | 95.72 (18.68) | 0.035 |
| (range 20–140) | Final | 19 | 109.30 (14.78) | 23 | 116.11 (14.67) | |
